Send to

Choose Destination
Eur J Neurol. 2010 Apr;17(4):562-6. doi: 10.1111/j.1468-1331.2009.02853.x. Epub 2009 Nov 24.

Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.

Author information

First Faculty of Medicine, Institute of Medical Biochemistry, Charles University, Prague, Czech Republic.



The aim of the study was to assess autoimmune involvement in amyotrophic lateral sclerosis (ALS).


We measured IgG antibodies against light (NFL) and medium (NFM) subunits of neurofilaments using ELISA in paired cerebrospinal fluid (CSF) and serum samples from 38 ALS patients and 20 controls.


Serum levels of anti-NFL were higher in ALS patients than in controls (P < 0.005). Serum anti-NFL antibodies and intrathecal anti-NFM antibodies were related to patient disability (serum anti-NFL: P < 0.05; intrathecal anti-NFM: P < 0.05). Anti-NFL levels were significantly correlated with anti-NFM levels in ALS (P < 0.001) and the control group (P < 0.0001) in the CSF, but not in serum. Anti-NFL and anti-NFM antibodies significantly correlated between serum and CSF in the ALS group (anti-NFL: P < 0.0001; anti-NFM: P < 0.001) and in the control group (anti-NFL: P < 0.05; anti-NFM: P < 0.05).


Autoimmune humoral response to neurocytoskeletal proteins is associated with ALS.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center